Cargando…

Regulatory Cells in Multiple Sclerosis: From Blood to Brain

Multiple sclerosis (MS) is a chronic, autoimmune, and neurodegenerative disease of the central nervous system (CNS) that affects myelin. The etiology of MS is unclear, although a variety of environmental and genetic factors are thought to increase the risk of developing the disease. Historically, T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calahorra, Leticia, Camacho-Toledano, Celia, Serrano-Regal, Mari Paz, Ortega, María Cristina, Clemente, Diego
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961785/ https://www.ncbi.nlm.nih.gov/pubmed/35203544 http://dx.doi.org/10.3390/biomedicines10020335

Ejemplares similares

Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
por: Camacho-Toledano, Celia, et al.
Publicado: (2022)

Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis
por: Ortega, María Cristina, et al.
Publicado: (2023)

Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers
por: Verreycken, Janne, et al.
Publicado: (2022)

Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients
por: Habib, Jakob, et al.
Publicado: (2015)

Antibody Content against Epstein–Barr Virus in Blood Extracellular Vesicles Correlates with Disease Activity and Brain Volume in Patients with Relapsing–Remitting Multiple Sclerosis
por: Fernández-Fournier, Mireya, et al.
Publicado: (2023)

Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?
por: Brancati, Serena, et al.
Publicado: (2021)

T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients
por: Dalla Libera, Dacia, et al.
Publicado: (2011)

Biomarkers Indicative of Blood-Brain Barrier Disruption in Multiple Sclerosis
por: Waubant, Emmanuelle
Publicado: (2006)

Effects of Systolic Blood Pressure on Brain Integrity in Multiple Sclerosis
por: Dossi, Daiana E., et al.
Publicado: (2018)

The Characterization of Regulatory T-Cell Profiles in Alzheimer’s Disease and Multiple Sclerosis
por: Ciccocioppo, Fausta, et al.
Publicado: (2019)

Regulatory T cells in multiple sclerosis and myasthenia gravis
por: Danikowski, K. M., et al.
Publicado: (2017)

Myeloid‐derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiation
por: Melero‐Jerez, Carolina, et al.
Publicado: (2020)

Copy number variations across the blood–brain barrier in multiple sclerosis
por: Bedri, Sahl Khalid, et al.
Publicado: (2022)

Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses
por: Hélie, Pauline, et al.
Publicado: (2021)

Permeability of the blood–brain barrier predicts conversion from optic neuritis to multiple sclerosis
por: Cramer, Stig P., et al.
Publicado: (2015)

No lack of regulatory B cells in patients with Multiple Sclerosis
por: Michel, Laure, et al.
Publicado: (2012)

Regulatory Functions of Natural Killer Cells in Multiple Sclerosis
por: Gross, Catharina C., et al.
Publicado: (2016)

Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?
por: Vasileiadis, Georgios K., et al.
Publicado: (2018)

Aluminium in Brain Tissue in Multiple Sclerosis
por: Mold, Matthew, et al.
Publicado: (2018)

Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis
por: De Stefano, Nicola, et al.
Publicado: (2017)

Reviewing the Significance of Blood–Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment
por: Balasa, Rodica, et al.
Publicado: (2021)

The Blood–Brain Barrier—A Key Player in Multiple Sclerosis Disease Mechanisms
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022)

Summary of Research: Collaboration Between Healthcare Professionals and People with Multiple Sclerosis to Develop Communication Tools to Improve the Standard of Multiple Sclerosis Care
por: Oreja-Guevara, Celia, et al.
Publicado: (2023)

Multiple Sclerosis Atlas: A Molecular Map of Brain Lesion Stages in Progressive Multiple Sclerosis
por: Frisch, Tobias, et al.
Publicado: (2020)

Retinal and Brain Microglia in Multiple Sclerosis and Neurodegeneration
por: Choi, Soyoung, et al.
Publicado: (2021)

Human Milk Oligosaccharides (HMOs) and Infant Microbiota: A Scoping Review
por: Sánchez, Cristina, et al.
Publicado: (2021)

Sera from Remitting and Secondary Progressive Multiple Sclerosis Patients Disrupt the Blood-Brain Barrier
por: Shimizu, Fumitaka, et al.
Publicado: (2014)

Fingolimod Prevents Blood-Brain Barrier Disruption Induced by the Sera from Patients with Multiple Sclerosis
por: Nishihara, Hideaki, et al.
Publicado: (2015)

Involvement of NINJ2 Protein in Inflammation and Blood–Brain Barrier Transmigration of Monocytes in Multiple Sclerosis
por: Sorosina, Melissa, et al.
Publicado: (2022)

Role of Regulatory T Cells in Pathogenesis and Biological Therapy of Multiple Sclerosis
por: Buc, Milan
Publicado: (2013)

PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption
por: Yun, Hyung-Mun, et al.
Publicado: (2015)

The role of fibronectin in multiple sclerosis and the effect of drug delivery across the blood-brain barrier
por: Wei, Shuang-Shuang, et al.
Publicado: (2023)

Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis
por: Iannello, Andrea, et al.
Publicado: (2019)

Functional and Structural Brain Plasticity Enhanced by Motor and Cognitive Rehabilitation in Multiple Sclerosis
por: Prosperini, Luca, et al.
Publicado: (2015)

Concurrence of Multiple Sclerosis and Brain Tumors
por: Plantone, Domenico, et al.
Publicado: (2015)

Iron and neurodegeneration in the multiple sclerosis brain
por: Hametner, Simon, et al.
Publicado: (2013)

Advances in brain imaging in multiple sclerosis
por: Cortese, Rosa, et al.
Publicado: (2019)

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
por: Serafini, Barbara, et al.
Publicado: (2007)

Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients
por: Chiarini, Marco, et al.
Publicado: (2020)

Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction
por: Kooij, Gijs, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2gqc0a3gdeij7bhq30vm3ffvl8